Aortic Valve Endothelial Cells Undergo Transforming Growth Factor-β-Mediated and Non-Transforming Growth Factor-β-Mediated Transdifferentiation in Vitro
- 1 October 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (4) , 1335-1343
- https://doi.org/10.1016/s0002-9440(10)62520-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A role for Smad6 in development and homeostasis of the cardiovascular systemNature Genetics, 2000
- Motility and invasion are differentially modulated by Rho family GTPasesOncogene, 2000
- A murine model of hereditary hemorrhagic telangiectasiaJournal of Clinical Investigation, 1999
- Soluble Transforming Growth Factor-β Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial GrowthCirculation Research, 1999
- Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the HeartScience, 1999
- Molecular Regulation of Atrioventricular Valvuloseptal MorphogenesisCirculation Research, 1995
- Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.Circulation Research, 1993
- In Vitro Cultivation and Immunogenicity of Human Cardiac Valve EndotheliumJournal of Cardiac Surgery, 1993
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986
- HUMAN VASCULAR ENDOTHELIAL CELLS IN CULTUREThe Journal of cell biology, 1974